Back to search

Article

Susceptibility trends of zoliflodacin against multidrug-resistant <i>Neisseria gonorrhoeae</i> clinical isolates in Nanjing, China (2014-2018)

2020-05-05

Abstract excerpt

<h4>ABSTRACT</h4> Previously, we reported potent activity of a novel spiropyrimidinetrione, zoliflodacin, against N. gonorrhoeae isolates from symptomatic men in Nanjing, China, collected in 2013. Here, we investigated trends of susceptibilities of zoliflodacin in 986 gonococcal isolates collected from men between 2014 and 2018. N. gonorrhoeae isolates were tested for susceptibility to zoliflodacin and seven ot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4666baa7-94fe-59f2-9fd7-359a2863bc86
DOI
10.1101/2020.05.04.078055
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Susceptibility trends of zoliflodacin against multidrug-resistant <i>Neisseria gonorrhoeae</i> clinical isolates in Nanjing, China (2014-2018)DOI 10.1101/2020.05.04.078055
In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae.Semantic proximity
Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.Semantic proximity
High In Vitro Susceptibility to the First-in-Class Spiropyrimidinetrione Zoliflodacin among Consecutive Clinical Neisseria gonorrhoeae Isolates from Thailand and South AfricaSemantic proximity
Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.Semantic proximity
Increasing Resistance to Azithromycin in Neisseria gonorrhoeae in Eastern Chinese Cities: Resistance Mechanisms and Genetic Diversity among Isolates from Nanjing.Semantic proximity
The distribution and spread of susceptible and resistant<i>Neisseria gonorrhoeae</i>across demographic groups in a major metropolitan centerSemantic proximity
The frequency of mutations in the<i>pen</i>A,<i>mtr</i>R,<i>gyr</i>A and<i>par</i>C genes of<i>Neisseria gonorrhoeae</i>, the presence of<i>tet</i>M gene and antibiotic resistance/susceptibility: a systematic review and meta-analysesSemantic proximity
Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeaeSemantic proximity
GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility.Semantic proximity
High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of GonorrheaSemantic proximity
Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015).Semantic proximity
Ceftriaxone-resistant<i>Neisseria gonorrhoeae</i>detected in England, 2015 to 2024; an observational studySemantic proximity
Select a neighboring publication to make it the new centre.